ReviewJournal of nanobiotechnology2026
Coordination chemistry-enabled drug delivery systems: metal-ligand platforms for controlled release and targeted therapeutics.
Review in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coordination chemistry presents an ideal molecular platform for the development of superior drug-delivery systems that can be effectively released, selectively targeted, and integrated into functional therapeutic systems. Due to their predictable geometries and tunable bonding properties, metal ions can form a variety of structures, including coordination polymer nanoparticles (CPNs), metal-organic frameworks (MOFs), supramolecular coordination complexes (SCCs), and metal-ligand cross-linked hydrogels. These structures possess a high cargo-loading ability and are sensitive to physiologically significant stimuli, including pH gradients, redox imbalances, enzymatic activity, and light. In addition to drug encapsulation, metal centers are intrinsically imaging-contrastive, catalytic, magnetically responsive, and phototherapeutic, enabling synergistic, multimodal therapies. This review critically analyzes the principles of coordination underlying the rational design of these delivery platforms, the key classes of coordination-based carriers, and their applications in cancer therapy, antimicrobial and antiviral treatment, gene and protein delivery, and theranostics. Emerging trends, such as hybrid organic-inorganic-bimolecular systems, hierarchical self-assembly, and AI-directed design, have also been described as definite areas of transformation in next-generation therapeutics. Issues related to physiological stability, metal toxicity, immune response, and scalable manufacturing are discussed, along with means to support clinical translation. Coordination-based architectures are expected to give the next generation of precise therapeutics that facilitate spectacular regulation of molecular assembly, dynamic reactions, and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.